newsfilter
← Latest News
GlobeNewswire·

Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

Translational data support the disease-modifying potential of pelabresib Central pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib treatment observed across a wide range of myelofibro